Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	52.08	89.14	60.08	127.68	59.25	100.85
Short-Term Investments	363.97	231.43	215.77	205.61	235.61	71.94
Cash & Short-Term Investments	416.05	320.57	275.85	333.29	294.86	172.79
Cash Growth	39.43%	16.21%	-17.23%	13.04%	70.64%	-40.92%
Receivables	33.03	18.51	14.87	6.22	1.03	-
Inventory	22.11	18.74	8.62	2.92	0.11	-
Other Current Assets	-	16.38	8.93	11.81	12.4	8.88
Total Current Assets	494.8	374.2	308.27	354.24	308.39	181.67
Property, Plant & Equipment	3.4	4.11	2.12	3.38	4.34	5
Other Intangible Assets	5.53	6.17	7.03	7.88	4.66	-
Long-Term Deferred Charges	-	6.21	12.59	-	-	-
Other Long-Term Assets	3.14	1.58	2.73	16.98	12.14	0.4
Total Assets	506.87	392.27	332.75	382.48	329.52	187.07
Accounts Payable	13.63	12.33	4.89	4.8	5.74	4.9
Accrued Expenses	81.06	58.31	42.85	30.48	29.26	12.56
Current Portion of Long-Term Debt	5.56	1.54	-	-	-	-
Current Portion of Leases	0.62	-	0.77	0.68	0.61	0.54
Current Unearned Revenue	-	1.29	1.29	1.43	7	-
Other Current Liabilities	3.4	42.05	5.41	2.42	0.83	-
Total Current Liabilities	104.27	115.52	55.2	39.81	43.43	17.99
Long-Term Debt	103.41	108.27	106.14	75.81	-	-
Long-Term Leases	3.52	3.94	0.49	1.26	1.95	2.55
Other Long-Term Liabilities	-	-	1.15	1.34	-	-
Total Liabilities	211.19	227.72	162.99	118.22	45.37	20.55
Common Stock	0.07	0.06	0.06	0.06	0.05	0.04
Additional Paid-In Capital	1,454	1,177	1,064	974.36	813.04	625.76
Retained Earnings	-1,304	-1,155	-894.74	-710.06	-528.94	-459.33
Comprehensive Income & Other	-0.93	-0.04	0.13	-0.09	-0	0.05
Total Common Equity	148.82	21.73	169.76	264.26	284.15	166.53
Shareholders' Equity	295.68	164.55	169.76	264.26	284.15	166.53
Total Liabilities & Equity	506.87	392.27	332.75	382.48	329.52	187.07
Total Debt	113.1	113.75	107.4	77.75	2.55	3.09
Net Cash (Debt)	302.95	206.82	168.44	255.53	292.3	169.71
Net Cash Growth	63.65%	22.78%	-34.08%	-12.58%	72.24%	-41.26%
Net Cash Per Share	4.76	3.39	2.92	4.90	5.89	3.85
Filing Date Shares Outstanding	66.74	63.22	60.14	56.75	50.33	50.18
Total Common Shares Outstanding	66.68	62.39	59.43	56.61	50.28	44.24
Working Capital	390.54	258.68	253.07	314.43	264.96	163.67
Book Value Per Share	2.23	0.35	2.86	4.67	5.65	3.76
Tangible Book Value	143.28	15.56	162.73	256.38	279.49	166.53
Tangible Book Value Per Share	2.15	0.25	2.74	4.53	5.56	3.76
Machinery	-	2.69	2.7	2.65	2.37	1.93
Leasehold Improvements	-	2.71	2.71	2.71	2.71	2.71

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q